Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01221805 · ClinicalTrials.gov registry record
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
A clinical trial, sponsored by Diagnostica Stago.
- Completed
- Registry status
- 2,040
- Enrollment target
NCT01221805: Completed study, sponsored by Diagnostica Stago.
NCT01221805 is a clinical trial that has completed, run by Diagnostica Stago. The registered enrollment target is 2,040 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01221805 has completed, sponsored by Diagnostica Stago.
- COMPLETED
- Registry status
- 2,040 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the ability of STA® Liatest® D-Di combined with a clinical pretest probability (PTP) to safely exclude pulmonary embolism (PE) or Deep Venous Thrombosis (DVT) in a 3 month follow-up.
Primary Outcome
Occurence of pulmonary embolism or deep venous thrombosis during the 3 month follow-up after negative diagnosis (i.e. patients with PTP low/moderate and negative STA Liatest D-Di test)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,040 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-04 |
What the finished NCT01221805 record still lists
NCT01221805 is an observational study that tracks outcomes without assigning an intervention. Its 2,040 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01221805 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01221805 about?
NCT01221805 is a clinical study titled "STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism". The purpose of this study is to demonstrate the ability of STA® Liatest® D-Di combined with a clinical pretest probability (PTP) to safely exclude pulmonary embolism (PE) or Deep Venous Thrombosis (DVT) in a 3 month follow-up.
What is the current status of trial NCT01221805?
This trial is currently completed. The enrollment target is 2,040 participants. The study started on 2011-11. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT01221805?
This trial is sponsored by Diagnostica Stago, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia